 Anticonvulsants
"Anticonvulsants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to prevent SEIZURES or reduce their severity.
| Descriptor ID |
D000927
|
| MeSH Number(s) |
D27.505.954.427.080
|
| Concept/Terms |
Anticonvulsants- Anticonvulsants
- Anticonvulsive Agents
- Agents, Anticonvulsive
- Anticonvulsive Drugs
- Drugs, Anticonvulsive
- Anticonvulsant Drugs
- Drugs, Anticonvulsant
Antiepileptic Agents- Antiepileptic Agents
- Agents, Antiepileptic
- Antiepileptics
- Antiepileptic Drugs
- Drugs, Antiepileptic
|
Below are MeSH descriptors whose meaning is more general than "Anticonvulsants".
Below are MeSH descriptors whose meaning is more specific than "Anticonvulsants".
This graph shows the total number of publications written about "Anticonvulsants" by people in this website by year, and whether "Anticonvulsants" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 | | 1997 | 0 | 1 | 1 | | 1998 | 3 | 1 | 4 | | 1999 | 0 | 1 | 1 | | 2000 | 2 | 0 | 2 | | 2001 | 3 | 0 | 3 | | 2002 | 0 | 1 | 1 | | 2003 | 2 | 0 | 2 | | 2004 | 1 | 4 | 5 | | 2005 | 1 | 3 | 4 | | 2006 | 1 | 5 | 6 | | 2007 | 2 | 2 | 4 | | 2008 | 3 | 1 | 4 | | 2009 | 5 | 1 | 6 | | 2010 | 5 | 1 | 6 | | 2011 | 2 | 4 | 6 | | 2012 | 5 | 3 | 8 | | 2013 | 2 | 2 | 4 | | 2014 | 2 | 1 | 3 | | 2015 | 6 | 2 | 8 | | 2016 | 6 | 1 | 7 | | 2017 | 8 | 3 | 11 | | 2018 | 5 | 3 | 8 | | 2019 | 6 | 8 | 14 | | 2020 | 9 | 6 | 15 | | 2021 | 5 | 5 | 10 | | 2022 | 2 | 9 | 11 | | 2023 | 4 | 7 | 11 | | 2024 | 4 | 4 | 8 | | 2025 | 11 | 2 | 13 | | 2026 | 8 | 3 | 11 |
To return to the timeline, click here.
Below are the most recent publications written about "Anticonvulsants" by people in Profiles.
-
Fukui S, Knupp KG. Dravet Syndrome Updates: Evolving Insights and Emerging Therapeutics. Curr Neurol Neurosci Rep. 2026 Oct 24; 26(1).
-
Nabbout R, Sullivan J, Auvin S, Cross JH, Devinsky O, Gil-Nagel A, Guerrini R, Knupp KG, Perry MS, Sánchez-Carpintero R, Schoonjans AS, Scheffer IE, Specchio N, Strzelczyk A, Wheless J, Wirrell EC, Morita D, Healy P, Langlois M, Lothe A, Lagae L. Efficacy and safety of fenfluramine in Dravet syndrome: The impact of patient clinical characteristics. Epilepsia Open. 2026 Oct; 11(5):1692-1705.
-
Nabbout R, Devinsky O, Lagae L, Scheffer IE, Guerrini R, Sullivan J, Gil-Nagel A, Zuberi SM, Riney K, Healy P, Abraham J, Roper RZ, Langlois M, Lothe A, Knupp KG. Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study. Epilepsia Open. 2026 Oct; 11(5):1871-1879.
-
Alshaqi O, Maisenbacher M, Nofal Y, Sane C, Hergenrader A, Schmidt C, Jennings C, Taraschenko O. Infertility treatment in women with epilepsy: A systematic review. Epilepsy Behav. 2026 Nov; 184:111210.
-
Gil-Nagel A, Knupp KG, Gunning B, Battaglia DI, Thiele EA, Scheffer IE, Schoonjans AS, Nabbout R, Villeneuve N, Klotz KA, Specchio N, Sanchez-Carpintero R, Zolnowska M, Schulz AL, Perrin L, Dickson N, Langlois M, Lothe A, Sullivan J. Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness. Epilepsia. 2026 Oct; 67(10):5227-5242.
-
Gilani K, Hanin A, Gaspard N, Batra A, Behrndt L, Day GS, Demeret S, Eschbach K, Foreman B, Gerard EE, Gofton TE, Gopaul MT, Haider HA, Hantus ST, Cobos-Hernandez C, Jimenez AD, Jongeling A, Kandula P, Kang P, Kazazian K, Kellogg M, Kim M, Farias-Moeller R, Morales M, Navarro V, Pimentel CM, Ramirez A, Steriade C, Struck AF, Taraschenko O, Wainwright MS, Zhou DJ, Hirsch LJ, Yoo JY. Acute and Long-Term EEG and seizure characteristics in new onset refractory status epilepticus (NORSE). Epilepsia. 2026 Sep; 67(9):4857-4869.
-
Potter SN, Petzold C, Garbarini K, Forsythe AN, Jalazo E, Gable J, Zentz S, Okoniewski KC, Alperin S, Berry-Kravis E, Bird LM, Carson RP, de Wit MY, Heimer G, Le Pichon JB, Lindsey W, Lowden A, Makowski C, Marsh E, Myers KA, Nangia S, Nespeca M, Roche-Martínez A, Schleifer P, Sell E, Thibert R, Walleigh D, Moore A, Wheeler A. Examining Epilepsy in Angelman Syndrome: Insights From Caregiver-Reported Data in the Linking Angelman and Dup15q Data for Expanded Research Database. Pediatr Neurol. 2026 Sep; 182:36-45.
-
Woodward J, Moore M, Strom L, Watson M, Pellinen J. Inappropriate prescribing of antiseizure medications in people with functional seizures: A call to action. Epilepsy Behav. 2026 Aug; 181:111087.
-
Pellinen J, Sillau S, Bui A, Danciutiu A, Kaye L, Sood A, Ferrari L, Rosenfeld WE, Elder C. Delayed and deferred surgery associated with cenobamate use in people with drug-resistant focal epilepsy. Epilepsia. 2026 Jul; 67(7):3410-3419.
-
Laux L, Sullivan J, Perry MS, Brunklaus A, Desurkar A, Schreiber JM, Roberts CM, Knupp KG, Wheless JW, Wirrell EC, Ventola P, Wang F, Lynch J, Parkerson KA, Ticho B, Cross JH. Zorevunersen in Children and Adolescents with Dravet Syndrome. N Engl J Med. 2026 Mar 05; 394(10):969-982.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|